Rita Aghjayan

Assistant Editor

Rita Aghjayan is assistant editor for The Clinical Advisor. She holds a BS in biology with minors in physics and chemistry from Pace University in New York. Prior to joining Haymarket, Rita conducted research both in quantum physics and microbial ecology.

All articles by Rita Aghjayan

General Oncology

Risk of SARS-CoV-2 Contamination in Radiation Oncology Clinics

Rita Aghjayan

October 2, 2020

While several studies have investigated SARS-CoV-2 contamination in health care settings, patterns in oncology clinics with fewer COVID-19 cases is unclear.

Hematologic Cancers

2020 Guidelines on Treating Acute Myeloid Leukemia in Older Adults

Rita Aghjayan

October 1, 2020

Recent guidelines have provided additional information on the treatment, management, and risk-stratifications of acute myeloid leukemia in older patients.

Healthcare workers intubating a COVID patient

Hematologic Cancers

COVID-19, SARS-CoV-2 Infection Phenotypes Vary With Different Tumor Subtypes

Rita Aghjayan

September 14, 2020

Among patients with cancer, tumor subtypes may influence varying susceptibility to SARS-CoV-2 and COVID-19 disease phenotypes.

Lymphoma

2021 Update on Diagnosis, Risk Stratification, and Management of Cutaneous B-Cell Lymphomas

Rita Aghjayan

September 9, 2020

Researchers assessed diagnosis, risk-stratification, and management of 3 distinct subgroups of primary cutaneous lymphomas.

Hematologic Cancers

Understanding the Association Between COVID-19, Thromboembolism, and Therapeutic Anticoagulation

Rita Aghjayan

August 31, 2020

In expanded research, investigators studied the effects of therapeutic and prophylactic anticoagulation treatment in hospitalized patients with COVID-19.

Hematologic Cancers

Older Patients With Previously Untreated AML May Benefit from Azacitidine, Venetoclax

Rita Aghjayan

August 25, 2020

Even after treatment with hypomethylating agents, older patients with AML still lack positive prognoses but azacitidine with venetoclax shows promise.